Physician profile
Joseph Eafrate
NPI 1689897738
$1,330.56
in general payments reported to CMS, 2019-2025
22 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $297 · 2022: $158 · 2023: $451 · 2024: $232 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $320.87 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $179.20 | 2021-2024 | |
| Novo Nordisk INC | $148.54 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $123.55 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $121.81 | 2025 | |
| Hologic Sales and Service, LLC | $82.40 | 2022-2023 | Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.09 | 2023-2025 | Jardiance |
| Lucid Diagnostics INC. | $41.01 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.76 | 2021 | |
| Eisai INC. | $22.91 | 2021 | |
| Dexcom, INC. | $22.10 | 2021 | |
| Astellas Pharma US INC | $18.23 | 2023 | Veozah |
| Sanofi Pasteur INC. | $17.83 | 2022 | |
| Baxter Healthcare | $17.52 | 2023 | Hillrom - Retinavue 700 Imager |
| Pfizer INC. | $17.43 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.39 | 2024 | Camzyos |
| Exact Sciences Corporation | $15.57 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $14.71 | 2021 | |
| Glaxosmithkline, LLC. | $13.87 | 2021 | |
| Inogen, INC. | $12.50 | 2024 | |
| Antares Pharma, INC. | $11.33 | 2021 | |
| Genentech USA, INC. | $2.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Eafrate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.